Award-winning fingerprint drug testing - quick, easy & hygienic

COVID-19 Fingerprint Test: Development Project

In response to the COVID-19 global emergency we’re focusing our development on a rapid point-of-care diagnostic for Coronavirus infection detection, with support from researchers at Imperial College London. We are seeking further partners to work with us and if you are interested in collaborating, please complete the form and outline your area of expertise.

Lord Darzi, Director of the Institute of Global Health Innovation at Imperial College London, has endorsed the project, commenting: “meeting UK COVID-19 testing goals is a critical part of our collective effort in controlling the virus, and fingerprint-based testing could, if developed, have an important role to play in accelerating the testing process. I’m supporting Intelligent Fingerprinting’s efforts to accelerate the development of this test, and am particularly keen to see other potential partners get involved as quickly as possible.”

Read press release

Send
Why fingerprint drug testing?

Our short video explains how fingerprint drug testing could support your organisation thanks to its non-invasive, quick and easy, more dignified approach. Please note that in the USA, the system is currently available for forensic use only.

Advantages of fingerprint drug testing

Uses

The Intelligent Fingerprinting Drug Screening System has been designed to simplify and support drug screening programs across a range of applications, subject to appropriate regulatory approval. Currently available in the USA for forensic use only.

Make an Inquiry

Fingerprint drug testing uses
Coronavirus (COVID-19)

In accordance with government regulations, many of our team are currently working remotely. Customer support, meetings and training are all fully available and being delivered virtually via telephone, Zoom and similar means. Please contact us via email at info@intelligentfingerprinting.com, or use our messaging service +44 (0)1223 941941 which is being regularly monitored.

News & Resources
View All
Download My Copy
Send